HPV B19 is a virus with a relatively high rate of infection in humans. Currently, there is no effective drug for its treatment, and symptomatic treatment is generally used.
When patients are infected with human HPV infection, the severity of their condition varies, some patients may be asymptomatic, some serious patients may experience organ failure, according to the relevant data show that some immunodeficiency patients infected with HPV may develop aplastic anemia, manifested as a decrease in white blood cells and platelets.
Currently, the symptomatic treatment of H. influenzae B19 infection is generally used, through intravenous injection of immunoglobulin containing H. influenzae B19 specific antibodies, which can neutralize the virus, reduce the viral load, and alleviate the clinical symptoms.
When the diagnosis of low platelet count due to HPV B19 infection is confirmed, the treatment should be standardized according to the doctor’s prescription, and should not be blindly self-medication.